Home › Multiple Myeloma › Iowa › Cedar Rapids
Pag-aaral pangklinika para sa Multiple Myeloma sa Cedar Rapids, IA
16 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cedar Rapids (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Nagre-recruitPhase 2
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
- University of Iowa Hospital and Clinics, Iowa City · 25 mi ang layo
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Nagre-recruitPhase 2
- University of Iowa, Iowa City · 25 mi ang layo
Collection of Tissue Samples for Cancer Research
Nagre-recruitObservasyonal na pag-aaral
- University of Iowa, Iowa City · 25 mi ang layo
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Nagre-recruitPhase 1/2
- Research Site, Iowa City · 25 mi ang layo
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 2
- University of Iowa, Iowa City · 25 mi ang layo
Limited-duration Teclistamab
Nagre-recruitPhase 2
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi ang layo
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi ang layo
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Nagre-recruitPhase 1
- Research Site, Iowa City · 25 mi ang layo
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Nagre-recruitPhase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Nagre-recruitPhase 3
- Research Site, Iowa City · 25 mi ang layo
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Nagre-recruitPhase 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi ang layo
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Nagre-recruitPhase 2
- University of Iowa, Iowa City · 25 mi ang layo
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
Nagre-recruitPhase 1
- University of Iowa Health Care, Iowa City · 25 mi ang layo
Sleep Apnea in Patients With MGUS and MM
Nagre-recruitObservasyonal na pag-aaral
- University of Iowa, Iowa City · 25 mi ang layo
Activity Levels in Bone Marrow Transplant Patients
Nagre-recruitObservasyonal na pag-aaral
- University of Iowa, Iowa City · 25 mi ang layo
Pag-aaral para sa Multiple Myeloma sa ibang lungsod
- New York City, NY59 pag-aaral
- Boston, MA45 pag-aaral
- Atlanta, GA42 pag-aaral
- Houston, TX39 pag-aaral
- Durham, NC36 pag-aaral
- Nashville, TN31 pag-aaral
- Denver, CO26 pag-aaral
- St. Louis, MO26 pag-aaral
- Rochester, MN25 pag-aaral
- Columbus, OH25 pag-aaral
- Chicago, IL24 pag-aaral
- Milwaukee, WI23 pag-aaral
Iba pang pag-aaral sa Cedar Rapids
- Non-Small Cell Lung Cancer23 pag-aaral
- Kanser sa Suso17 pag-aaral
- Kanser (lahat ng uri)17 pag-aaral
- Kanser sa Baga17 pag-aaral
- Acute Myeloid Leukemia15 pag-aaral
- Colorectal Cancer14 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg13 pag-aaral
- Kanser sa Prostate12 pag-aaral
- Melanoma11 pag-aaral
- Metastatic Cancer9 pag-aaral
- Kanser sa Dugo9 pag-aaral
- Kanser sa Ovary9 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.